<DOC>
	<DOCNO>NCT00193687</DOCNO>
	<brief_summary>Study long-term efficacy safety bifeprunox treatment schizophrenia . Extension study S154.3.001 .</brief_summary>
	<brief_title>Bifeprunox Treatment Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>diagnosis schizophrenia , understand nature study , able manage outpatient set longterm bifeprunox treatment current primary diagnosis schizophrenia , suicide risk , diagnosis history substance abuse , uncontrolled hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>open-label study treatment schizophrenia</keyword>
</DOC>